Published in Catheter Cardiovasc Interv on December 04, 2013
Long-term results of percutaneous balloon valvuloplasty of congenital aortic stenosis in adolescents and young adults. Indian Heart J (2016) 0.77
Ballooning the aortic valve under pressure. Catheter Cardiovasc Interv (2014) 0.75
Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. Am J Physiol (1958) 7.03
Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol (2009) 2.96
Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation (1994) 1.95
Predictors of event-free survival after balloon aortic valvuloplasty. N Engl J Med (1991) 1.78
The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic stenosis. J Am Coll Cardiol (1994) 1.72
Aortic stenosis in elderly patients aged 80 or older. Treatment by percutaneous balloon valvuloplasty in a series of 92 cases. Circulation (1989) 1.47
Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation (1991) 1.40
Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J Am Coll Cardiol (1995) 1.27
Left ventricular end-diastolic pressure and risk of subsequent heart failure in patients following an acute myocardial infarction. Congest Heart Fail (2007) 1.04
Left ventricular end-diastolic pressure is a predictor of mortality in cardiac surgery independently of left ventricular ejection fraction. Br J Anaesth (2006) 0.98
Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB). J Cardiothorac Surg (2009) 0.97
Predictors of long-term survival after percutaneous aortic valvuloplasty: report of the Mansfield Scientific Balloon Aortic Valvuloplasty Registry. J Am Coll Cardiol (1991) 0.94
Predictive accuracy of EuroSCORE: is end-diastolic dysfunction a missing variable? Eur J Cardiothorac Surg (2009) 0.87
A novel clinical prediction rule for 30-day mortality following balloon aortic valuloplasty: the CRRAC the AV score. Catheter Cardiovasc Interv (2011) 0.87
Balloon valvuloplasty in adult aortic stenosis: determinants of clinical outcome. Ann Intern Med (1989) 0.86
Percutaneous transluminal aortic valvuloplasty: acute outcome and follow-up of 125 patients. J Am Coll Cardiol (1989) 0.85
Comparison of procedural and in-hospital outcomes of percutaneous balloon aortic valvuloplasty in patients >80 years versus patients < or =80 years. Am J Cardiol (2010) 0.85
Failure of balloon aortic valvuloplasty to result in sustained clinical improvement in patients with depressed left ventricular function. Am J Cardiol (1990) 0.85
Determinants of one-year outcome from balloon aortic valvuloplasty. Am J Cardiol (1991) 0.84
Hemodynamic support with impella 2.5 during balloon aortic valvuloplasty in a high-risk patient. J Interv Cardiol (2011) 0.82
Increased extravascular forces limit endothelium-dependent and -independent coronary vasodilation in congestive heart failure. Cardiovasc Res (2001) 0.80
Percutaneous transluminal aortic valvuloplasty--the acute outcome and follow-up of 149 patients who underwent the double balloon technique. Eur Heart J (1990) 0.80
Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation (2002) 2.52
Management of platypnea-orthodeoxia syndrome by transcatheter closure of atrial communication: hemodynamic characteristics, clinical and echocardiographic outcome. J Invasive Cardiol (2004) 2.48
Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest (2008) 2.46
Sex differences in medical care and early death after acute myocardial infarction. Circulation (2008) 2.17
Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Eur Heart J (2006) 2.14
The changing pattern of coronary perforation during percutaneous coronary intervention in the new device era. J Invasive Cardiol (2004) 1.87
Complete pulmonary venous occlusion after radiofrequency ablation for atrial fibrillation. Ann Thorac Surg (2009) 1.79
Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol (2005) 1.77
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv (2009) 1.76
Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol (2008) 1.73
Novel use of the Amplatzer septal occluder device in the percutaneous closure of ascending aortic pseudoaneurysms: a case series. Catheter Cardiovasc Interv (2007) 1.65
May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association. Stroke (2009) 1.58
Percutaneous septal sinus shortening: a novel procedure for the treatment of functional mitral regurgitation. Circulation (2006) 1.57
Impact of rapid ventricular pacing during percutaneous balloon aortic valvuloplasty in patients with critical aortic stenosis: should we be using it? Catheter Cardiovasc Interv (2010) 1.57
Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol (2009) 1.54
What are the differences in presentation of candidates for percutaneous mitral commissurotomy across the world and do they influence the results of the procedure? Arch Cardiovasc Dis (2008) 1.54
Retrograde versus antegrade percutaneous aortic balloon valvuloplasty: immediate, short- and long-term outcome at 2 years. Catheter Cardiovasc Interv (2009) 1.54
Trends in coronary revascularization in the United States from 2001 to 2009: recent declines in percutaneous coronary intervention volumes. Circ Cardiovasc Qual Outcomes (2011) 1.51
Long-term experience and outcomes with transcatheter closure of patent foramen ovale. JACC Cardiovasc Interv (2013) 1.50
Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ΙΙ study. Catheter Cardiovasc Interv (2013) 1.50
ST-elevation myocardial infarction mortality in a major academic center "on-" versus "off-" hours. J Invasive Cardiol (2009) 1.49
Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv (2013) 1.48
Hemodynamic effects of inhaled nitric oxide in right ventricular myocardial infarction and cardiogenic shock. J Am Coll Cardiol (2004) 1.47
Images in cardiovascular medicine. Covered stent septal ablation for hypertrophic obstructive cardiomyopathy: initial success but ultimate failure resulting from collateral formation. Circulation (2003) 1.47
Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up. Catheter Cardiovasc Interv (2010) 1.41
Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes. Catheter Cardiovasc Interv (2009) 1.40
Compassionate use of the amplatzer ASD closure device for residual postinfarction ventricular septal rupture following surgical repair. Catheter Cardiovasc Interv (2003) 1.39
Patients with small left ventricular size undergoing balloon aortic valvuloplasty have worse intraprocedural outcomes. Catheter Cardiovasc Interv (2012) 1.39
Impact of time of presentation on the care and outcomes of acute myocardial infarction. Circulation (2008) 1.39
Rapid-exchange guide catheter extension for extending the reach of an AL3 guide in a patient with a long, dilated ascending aorta. Catheter Cardiovasc Interv (2012) 1.38
Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J (2013) 1.35
Percutaneous transcatheter patent foramen ovale closure using the right internal jugular venous approach. Catheter Cardiovasc Interv (2003) 1.30
Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention (2016) 1.11
Association between self-replicating calcifying nanoparticles and aortic stenosis: a possible link to valve calcification. Eur Heart J (2008) 1.08
The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease. Pharmacol Ther (2013) 1.07
Endovascular therapy for left main compression syndrome. Case report and literature review. Chest (2009) 1.03
Intravascular detection of the vulnerable plaque. Circ Cardiovasc Imaging (2011) 1.03
Images in cardiovascular medicine. Visualization of endomyocardial fibrosis by delayed-enhancement magnetic resonance imaging. Circulation (2005) 1.02
Real-time three-dimensional transesophageal echocardiography in patients with secundum atrial septal defects: outcomes following transcatheter closure. J Am Soc Echocardiogr (2011) 1.01
Echocardiographic assessment of percutaneous patent foramen ovale and atrial septal defect closure complications. Circ Cardiovasc Imaging (2009) 1.00
Percutaneous approaches to valvular disease. Circulation (2004) 0.96
Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol (2006) 0.95
Relation of circulating C-reactive protein to progression of aortic valve stenosis. Am J Cardiol (2005) 0.93
Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. JACC Cardiovasc Interv (2012) 0.93
Images in cardiovascular medicine. Giant left circumflex coronary artery aneurysm with arteriovenous fistula to the coronary sinus. Circulation (2008) 0.90
Platypnea-Orthodeoxia Syndrome in Two Previously Healthy Adults: A Case-based Review. Clin Med Cardiol (2009) 0.90
Aneurysm of the Vieussens' arterial ring. J Invasive Cardiol (2007) 0.90
Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease. Catheter Cardiovasc Interv (2008) 0.90
Transthoracic left ventricular puncture for the assessment of patients with aortic and mitral valve prostheses: the Massachusetts General Hospital experience, 1989-2000. Catheter Cardiovasc Interv (2003) 0.90
Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry. Eur Heart J (2007) 0.88
[Patent foramen ovale: current state of the art]. Rev Esp Cardiol (2008) 0.88
Acute myocardial infarction caused by multivessel coronary spasm due to calcium channel blocker withdrawal. Catheter Cardiovasc Interv (2011) 0.87
Drug-eluting stents for diabetes mellitus: a rush to judgment? J Am Coll Cardiol (2005) 0.87
Comparison of sixty-four-slice multidetector computed tomographic coronary angiography to coronary angiography with intravascular ultrasound for the detection of transplant vasculopathy. Am J Cardiol (2006) 0.86
Immediate and long-term follow-up of percutaneous balloon mitral valvuloplasty in pregnant patients with rheumatic mitral stenosis. Am J Cardiol (2006) 0.86
Comparison of procedural and in-hospital outcomes of percutaneous balloon aortic valvuloplasty in patients >80 years versus patients < or =80 years. Am J Cardiol (2010) 0.85
Impact of concomitant aortic regurgitation on percutaneous mitral valvuloplasty: Immediate results, short-term, and long-term outcome. Am Heart J (2008) 0.85
Imaging of atrial septal defects: echocardiography and CT correlation. Heart (2011) 0.84
Systematic review and cost-benefit analysis of radial artery access for coronary angiography and intervention. Circ Cardiovasc Qual Outcomes (2012) 0.84
Predictors of long-term mortality in patients with ischemic stroke referred for transesophageal echocardiography. Stroke (2005) 0.84
Analysis of cardiac dimensions, mass and function in heart transplant recipients using 64-slice multi-detector computed tomography. J Heart Lung Transplant (2007) 0.84
Acute predictors of subacute complete heart block after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol (2005) 0.83
Short-term pacing in the mouse alters cardiac expression of connexin43. BMC Physiol (2008) 0.82
Cardiac fat-containing lesions are common in tuberous sclerosis complex. Am J Med Genet A (2013) 0.82
Structural heart intervention. Beyond transcatheter valve therapy. Rev Esp Cardiol (Engl Ed) (2012) 0.82
Catheter pericardiocentesis for delayed tamponade after cardiac valve operation. Ann Thorac Surg (2002) 0.82
Suicide left ventricle following transcatheter aortic valve implantation. Catheter Cardiovasc Interv (2010) 0.81
The echo score revisited: Impact of incorporating commissural morphology and leaflet displacement to the prediction of outcome for patients undergoing percutaneous mitral valvuloplasty. Circulation (2013) 0.81
Spontaneous spiral dissection of a LIMA-LAD bypass graft: a case report. J Interv Cardiol (2004) 0.81
Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis. J Am Coll Cardiol (2006) 0.80
Frequency and mechanism of persistent systolic anterior motion and mitral regurgitation after septal ablation in obstructive hypertrophic cardiomyopathy. Am J Cardiol (2007) 0.80
Identification of binding partners for the cytoplasmic loop of connexin43: a novel interaction with β-tubulin. Cell Commun Adhes (2009) 0.80
Effect of cytokine hemoadsorption on brain death-induced ventricular dysfunction in a porcine model. J Thorac Cardiovasc Surg (2012) 0.80